Company record
AcelRx Pharmaceuticals, Inc.
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about AcelRx Pharmaceuticals, Inc..
Warning letters
-
DrugsAcelRx Pharmaceuticals, Inc.
FDA says AcelRx's DSUVIA banner and display ads misbrand the opioid tablet by oversimplifying dosing and understating risks.
High risk